CD274 and neoplasm: ICB against cell-surface-expressed PDL1 is well known and investigated, but recent evidence for immunopathogenic tumor-intrinsic PDL1 signals demonstrates additional PDL1 effects that are important in treatment resistance and that are aside from its canonical surface role [6].